• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 刺突蛋白结构。

Structure of SARS-CoV-2 spike protein.

机构信息

Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, United States; Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA 02115, United States.

Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, United States; Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA 02115, United States.

出版信息

Curr Opin Virol. 2021 Oct;50:173-182. doi: 10.1016/j.coviro.2021.08.010. Epub 2021 Sep 8.

DOI:10.1016/j.coviro.2021.08.010
PMID:34534731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423807/
Abstract

The COVID-19 (coronavirus disease 2019) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to loss of human life in millions and devastating socio-economic consequences worldwide. The disease has created urgent needs for intervention strategies to control the crisis and meeting these needs requires a deep understanding of the structure-function relationships of viral proteins and relevant host factors. The trimeric spike (S) protein of the virus decorates the viral surface and is an important target for development of diagnostics, therapeutics and vaccines. Rapid progress in the structural biology of SARS-CoV-2 S protein has been made since the early stage of the pandemic, advancing our knowledge on the viral entry process considerably. In this review, we summarize our latest understanding of the structure of the SARS-CoV-2 S protein and discuss the implications for vaccines and therapeutics.

摘要

新型冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起的一种疾病,导致数百万人失去生命,并在全球范围内造成破坏性的社会经济后果。该疾病急需干预策略来控制危机,而满足这些需求需要深入了解病毒蛋白和相关宿主因素的结构-功能关系。病毒的三聚体刺突(S)蛋白装饰着病毒表面,是开发诊断、治疗和疫苗的重要目标。自大流行早期以来,SARS-CoV-2 S 蛋白的结构生物学取得了快速进展,大大提高了我们对病毒进入过程的认识。在这篇综述中,我们总结了对 SARS-CoV-2 S 蛋白结构的最新理解,并讨论了其对疫苗和治疗的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/89403e9ae2f5/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/6aee7fa995ca/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/5f472c96165a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/507b6f8fee19/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/2e4733993008/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/89403e9ae2f5/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/6aee7fa995ca/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/5f472c96165a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/507b6f8fee19/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/2e4733993008/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2451/8423807/89403e9ae2f5/gr5_lrg.jpg

相似文献

1
Structure of SARS-CoV-2 spike protein.SARS-CoV-2 刺突蛋白结构。
Curr Opin Virol. 2021 Oct;50:173-182. doi: 10.1016/j.coviro.2021.08.010. Epub 2021 Sep 8.
2
The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.SARS-CoV-2 刺突糖蛋白作为药物和疫苗靶点:与 ACE2 和抗体复合物的结构见解。
Cells. 2020 Oct 22;9(11):2343. doi: 10.3390/cells9112343.
3
Making sense of spike D614G in SARS-CoV-2 transmission.解读新冠病毒传播中的刺突蛋白D614G突变
Sci China Life Sci. 2021 Jul;64(7):1062-1067. doi: 10.1007/s11427-020-1893-9. Epub 2021 Feb 4.
4
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
5
The structural basis of accelerated host cell entry by SARS-CoV-2†.SARS-CoV-2 加速宿主细胞进入的结构基础。
FEBS J. 2021 Sep;288(17):5010-5020. doi: 10.1111/febs.15651. Epub 2020 Dec 14.
6
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.阻断 N-和 O-聚糖的合成可抑制 SARS-CoV-2 病毒进入。
Elife. 2020 Oct 26;9:e61552. doi: 10.7554/eLife.61552.
7
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.基于 SARS-CoV-2 刺突糖蛋白与 ACE-2 受体同源物和人类 TLR 相互作用的比较特征的计算机研究。
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.
8
Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.橙皮苷通过阻断刺突蛋白 RBD 与人 ACE2 受体之间的相互作用来抑制 SARS-CoV-2 的进入。
Int J Mol Sci. 2021 Aug 10;22(16):8604. doi: 10.3390/ijms22168604.
9
Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.COVID-19 的 SARS-CoV-2 刺突(RBD 结构域)多价展示到纳米材料、蛋白铁蛋白纳米笼上。
Biomolecules. 2021 Feb 17;11(2):297. doi: 10.3390/biom11020297.
10
Inhibition of Coronavirus Entry and by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.脂肽抑制新型冠状病毒和严重急性呼吸综合征冠状病毒进入宿主细胞
mBio. 2020 Oct 20;11(5):e01935-20. doi: 10.1128/mBio.01935-20.

引用本文的文献

1
Heterogeneous Evolution Among SARS-CoV-2 Genes and Variants of Concern.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因与关注变异株之间的异质性进化
J Med Virol. 2025 Sep;97(9):e70604. doi: 10.1002/jmv.70604.
2
An In Silico Investigation of Brazilian Green Propolis Extracts as Potential Treatment for COVID-19.巴西绿蜂胶提取物作为 COVID-19 潜在治疗方法的计算机模拟研究。
ACS Omega. 2025 Aug 5;10(32):35651-35665. doi: 10.1021/acsomega.5c02121. eCollection 2025 Aug 19.
3
An Italian Single-Center Genomic Surveillance Study: Two-Year Analysis of SARS-CoV-2 Spike Protein Mutations.

本文引用的文献

1
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.用于识别不断演变的新冠病毒刺突蛋白的记忆B细胞库。
Cell. 2021 Sep 16;184(19):4969-4980.e15. doi: 10.1016/j.cell.2021.07.025. Epub 2021 Jul 23.
2
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.SARS-CoV-2 天然突变对刺突结构、构象和抗原性的影响。
Science. 2021 Aug 6;373(6555). doi: 10.1126/science.abi6226. Epub 2021 Jun 24.
3
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
一项意大利单中心基因组监测研究:新冠病毒刺突蛋白突变的两年分析
Int J Mol Sci. 2025 Aug 5;26(15):7558. doi: 10.3390/ijms26157558.
4
SARITA: a large language model for generating the S1 subunit of the SARS-CoV-2 spike protein.SARITA:一种用于生成严重急性呼吸综合征冠状病毒2刺突蛋白S1亚基的大语言模型。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf384.
5
Identification of SARS-CoV-2-binding lectins on a commercial lectin array.在商业凝集素芯片上鉴定严重急性呼吸综合征冠状病毒2(SARS-CoV-2)结合凝集素
Sci Rep. 2025 Jul 1;15(1):21687. doi: 10.1038/s41598-025-01903-5.
6
Resurrection of the Helical Hairpin Hypothesis for Understanding Coronavirus Fusion.复活螺旋发夹假说以理解冠状病毒融合机制
J Membr Biol. 2025 Jun 24. doi: 10.1007/s00232-025-00350-7.
7
Immunotherapeutic Approach for Improving the Efficacy of a Novel Subunit Vaccine Against SARS-CoV-2 by Cytotoxic T-Lymphocytes (CTL) Epitopes.通过细胞毒性T淋巴细胞(CTL)表位提高新型SARS-CoV-2亚单位疫苗疗效的免疫治疗方法。
Scientifica (Cairo). 2025 May 26;2025:6025826. doi: 10.1155/sci5/6025826. eCollection 2025.
8
The Binding of Brazilin from to the Full-Length SARS-CoV-2 Spike Proteins.来自[具体来源]的巴西苏木素与全长严重急性呼吸综合征冠状病毒2刺突蛋白的结合。
Int J Mol Sci. 2025 Apr 25;26(9):4100. doi: 10.3390/ijms26094100.
9
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白突变与全球新冠疫苗有效性的交叉分析
Front Immunol. 2025 Mar 7;16:1435873. doi: 10.3389/fimmu.2025.1435873. eCollection 2025.
10
SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding.严重急性呼吸综合征相关冠状病毒S蛋白结构揭示了支撑高亲和力人类血管紧张素转换酶2结合的协同受体结合基序相互作用。
Sci Adv. 2025 Mar 14;11(11):eadr8772. doi: 10.1126/sciadv.adr8772.
SARS-CoV-2 变体增强感染性和免疫逃避的结构基础。
Science. 2021 Aug 6;373(6555):642-648. doi: 10.1126/science.abi9745. Epub 2021 Jun 24.
4
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.普遍存在、具有保护作用且趋同的针对 SARS-CoV-2 非 RBD 刺突表位的 IgG 识别。
Science. 2021 Jun 4;372(6546):1108-1112. doi: 10.1126/science.abg5268. Epub 2021 May 4.
5
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.针对刺突 N 端结构域的强效 SARS-CoV-2 中和抗体靶向单一超位点。
Cell Host Microbe. 2021 May 12;29(5):819-833.e7. doi: 10.1016/j.chom.2021.03.005. Epub 2021 Mar 12.
6
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.N 端结构域抗原性分析揭示了 SARS-CoV-2 的一个弱点。
Cell. 2021 Apr 29;184(9):2332-2347.e16. doi: 10.1016/j.cell.2021.03.028. Epub 2021 Mar 16.
7
Structural impact on SARS-CoV-2 spike protein by D614G substitution.D614G 取代对 SARS-CoV-2 刺突蛋白结构的影响。
Science. 2021 Apr 30;372(6541):525-530. doi: 10.1126/science.abf2303. Epub 2021 Mar 16.
8
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
9
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.SARS-CoV-2 刺突糖蛋白的反复缺失可导致抗体逃逸。
Science. 2021 Mar 12;371(6534):1139-1142. doi: 10.1126/science.abf6950. Epub 2021 Feb 3.
10
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies.结构分析 SARS-CoV-2 刺突蛋白的中和表位以指导治疗和疫苗设计策略。
Viruses. 2021 Jan 19;13(1):134. doi: 10.3390/v13010134.